[Porphyromonas gingivalis persisters induce the immuno-inflammatory responses in macrophages by upregulating the

C Wang1, L L Wang2, X Li3

  • 1Department of Periodontology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.

Insights

Porphyromonas gingivalis persisters (PgPs) are tolerant to antibiotics and enhance inflammatory responses in macrophages by activating the FOXO1 pathway. Inhibiting FOXO1 reduces this inflammatory effect, suggesting a therapeutic target.

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Context:

  • Porphyromonas gingivalis (Pg) persisters (PgPs) are resilient bacterial forms.
  • Antibiotic treatment can select for these persistent bacterial populations.
  • Understanding PgPs' interaction with host immune cells is crucial for treating chronic infections.

Purpose:

  • To investigate the impact of PgPs on macrophage immuno-inflammatory responses.
  • To explore the role of the FOXO1 signaling pathway in mediating these responses.
  • To assess the efficacy of antibiotic treatments against PgPs.

Summary:

  • PgPs demonstrated high tolerance to metronidazole and amoxicillin, maintaining viability and colony-forming ability.
  • Both Pg and antibiotic-treated PgPs (M-PgPs) induced significant upregulation of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α) in macrophages.
  • This inflammatory enhancement was mediated by the upregulation of the FOXO1 signaling pathway, with inhibition reducing cytokine levels and activation exacerbating them.

Impact:

  • PgPs contribute to heightened immuno-inflammatory responses in macrophages.
  • The FOXO1 signaling pathway is a key mediator of PgPs-induced inflammation.
  • Targeting the FOXO1 pathway may offer a novel therapeutic strategy against Pg-associated inflammatory conditions.